Research Article
Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary®): Results of a Nationwide Dose Conversion Survey
Table 3
CD-LD IR to CD-LD ER dose conversion ratio.
| | n (%) |
| Based on total daily CD-LD IR dose (n = 44) | | 2x CD-LD IR dose | 35 (80) | 2.1–2.4x CD-LD IR dose | 5 (11) | >2.4x CD-LD IR dose | 1 (2) | Depends on CD-LD IR dose | 3 (7) |
| Based on individual CD-LD IR dose (n = 18) | | 2.5–2.9x CD-LD IR dose | 9 (50) | 3x CD-LD IR dose | 5 (28) | 3.1–3.5x CD-LD IR dose | 0 | Depends on CD-LD IR dose | 4 (22) |
|
|
CD-LD = carbidopa-levodopa; IR = immediate-release; ER = extended-release.
|